| PATENTS
Upstream has filed five (5) provisional patents and has a proprietary discovery pipeline that the Company would like to see generate a stream of intellectual property.
1. Drug Response Diagnostics
A novel test for predicting the impact of genetic variations on patient drug reaction.
2. Liver Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of getting liver cancer.
3. Prostate Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of getting prostate cancer.
4. Ovarian Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of getting ovarian cancer.
5. Thyroid Cancer Susceptibility Test
Genetic variations that determine a patients’ risk of getting thyroid cancer.
|
